{'fraction_non_alphanumeric': 0.015384615384615385, 'fraction_numerical': 0.00641025641025641, 'mean_word_length': 5.401639344262295, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
PTCA versus CABG for Multivessel Coronary Artery Disease: Where Do We Stands?

The results of several large randomized trials comparing surgery vs angioplasty for the treatment of multivessel coronary artery disease recently have been reported. A number of large nonrandomized comparison studies also have examined the outcomes of these two treatments. Most studies have found similar in-hospital morbidity and mortality rates for both procedures. Furthermore, at follow-up times of 1 year or greater, there are generally no differences in rates of death or myocardial infarction, but all trials show an increased need for repeat revascularization in patients initially treated with angioplasty.The results of the largest randomized trial to date are anticipated in November 1995.